These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8425767)
21. Permissive role of polyamines in the cooperative action of estrogens and insulin or insulin-like growth factor I on human breast cancer cell growth. Huber M; Poulin R J Clin Endocrinol Metab; 1996 Jan; 81(1):113-23. PubMed ID: 8550737 [TBL] [Abstract][Full Text] [Related]
22. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-I signaling. Varma H; Conrad SE Cancer Res; 2002 Jul; 62(14):3985-91. PubMed ID: 12124331 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Watson PH; Pon RT; Shiu RP Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215 [TBL] [Abstract][Full Text] [Related]
24. Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Eppenberger U; Wosikowski K; Küng W Am J Clin Oncol; 1991; 14 Suppl 2():S5-14. PubMed ID: 1962598 [TBL] [Abstract][Full Text] [Related]
25. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen. Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409 [TBL] [Abstract][Full Text] [Related]
26. Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line. Li XS; Chen JC; Sheikh MS; Shao ZM; Fontana JA Exp Cell Res; 1994 Mar; 211(1):68-73. PubMed ID: 8125161 [TBL] [Abstract][Full Text] [Related]
27. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. Leung LK; Wang TT Br J Cancer; 1999 Oct; 81(3):387-92. PubMed ID: 10507761 [TBL] [Abstract][Full Text] [Related]
28. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093 [TBL] [Abstract][Full Text] [Related]
29. Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Schmitt M; Klinga K; Schnarr B; Morfin R; Mayer D Mol Cell Endocrinol; 2001 Feb; 173(1-2):1-13. PubMed ID: 11223173 [TBL] [Abstract][Full Text] [Related]
30. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Huynh H; Nickerson T; Pollak M; Yang X Clin Cancer Res; 1996 Dec; 2(12):2037-42. PubMed ID: 9816164 [TBL] [Abstract][Full Text] [Related]
31. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro. Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399 [TBL] [Abstract][Full Text] [Related]
32. Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice. Wärri AM; Laine AM; Majasuo KE; Alitalo KK; Härkönen PL Int J Cancer; 1991 Oct; 49(4):616-23. PubMed ID: 1680817 [TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152 [TBL] [Abstract][Full Text] [Related]
34. Laminin inhibits estrogen action in human breast cancer cells. Woodward TL; Lu H; Haslam SZ Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
36. Acetaminophen-induced proliferation of estrogen-responsive breast cancer cells is associated with increases in c-myc RNA expression and NF-kappaB activity. Gadd SL; Hobbs G; Miller MR Toxicol Sci; 2002 Apr; 66(2):233-43. PubMed ID: 11896290 [TBL] [Abstract][Full Text] [Related]
37. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Dubik D; Dembinski TC; Shiu RP Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090 [TBL] [Abstract][Full Text] [Related]
38. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation. Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281 [TBL] [Abstract][Full Text] [Related]
39. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Huynh H; Yang XF; Pollak M Cell Growth Differ; 1996 Nov; 7(11):1501-6. PubMed ID: 8930399 [TBL] [Abstract][Full Text] [Related]
40. Selective modulation of protein kinase A and protein kinase C activities in epidermal growth factor (EGF)-stimulated MCF-7 breast cancer cells. Mueller H; Liu R; David F; Eppenberger U Biol Chem; 1997 Sep; 378(9):1023-9. PubMed ID: 9348112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]